| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.039 | 0.8 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.035 | 0.9 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.029 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.034 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.9 |